Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Transcriptional Control and Deregulation, Signal Transduction and Cytokines

Human telomerase is regulated by erythropoietin and transforming growth factor-β in human erythroid progenitor cells

Abstract

Telomerase catalytic subunit (hTERT) exerts important cellular functions including telomere homeostasis, genetic stability, cell survival and perhaps differentiation. However, the nature of external or internal signals, which regulate hTERT expression in tissues, remains poorly understood. Thus, whereas it has been described that hTERT gene is regulated along the differentiation of primitive myeloid progenitors, the effect of specific cytokines on telomerase expression in each myeloid lineage is currently unknown. Based on these considerations, we have investigated hTERT expression in erythroid cells treated with erythropoietin (EPO) and transforming growth factor β (TGFβ), as putative positive and negative regulators, respectively. We describe here that EPO activates hTERT gene transcription in in vitro-expanded primary erythroid precursors as well as in UT7 erythroleukemia cells. In UT7 cells, this study shows also that EPO acts through a JAK2/STAT5/c-myc axis. In contrast, TGFβ blocks EPO signaling downstream of c-myc induction through a Smad3-dependent mechanism. Finally, hTERT appears to be efficiently regulated by EPO and TGFβ in an opposite way in erythropoietic cells, arguing for a role of telomerase in red blood cell production.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011–2015.

    Article  CAS  Google Scholar 

  2. Kirkpatrick KL, Clark G, Ghilchick M, Newbold RF, Mokbel K . hTERT mRNA expression correlates with telomerase activity in human breast cancer. Eur J Surg Oncol 2003; 29: 321–326.

    Article  CAS  Google Scholar 

  3. Engelhardt M, Kumar R, Albanell J, Pettengell R, Han W, Moore MA . Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells. Blood 1997; 90: 182–193.

    CAS  PubMed  Google Scholar 

  4. Beyne-Rauzy O, Recher C, Dastugue N, Demur C, Pottier G, Laurent G et al. Tumor necrosis factor alpha induces senescence and chromosomal instability in human leukemic cells. Oncogene 2004; 23: 7507–7516.

    Article  CAS  Google Scholar 

  5. Hahn WC, Stewart SA, Brooks MW, York SG, Eaton E, Kurachi A et al. Inhibition of telomerase limits the growth of human cancer cells. Nat Med 1999; 5: 1164–1170.

    Article  CAS  Google Scholar 

  6. Delhommeau F, Thierry A, Feneux D, Lauret E, Leclercq E, Courtier MH et al. Telomere dysfunction and telomerase reactivation in human leukemia cell lines after telomerase inhibition by the expression of a dominant-negative hTERT mutant. Oncogene 2002; 21: 8262–8271.

    Article  CAS  Google Scholar 

  7. Endoh T, Tsuji N, Asanuma K, Yagihashi A, Watanabe N . Survivin enhances telomerase activity via up-regulation of specificity protein 1- and c-Myc-mediated human telomerase reverse transcriptase gene transcription. Exp Cell Res 2005; 305: 300–311.

    Article  CAS  Google Scholar 

  8. Beyne-Rauzy O, Prade-Houdellier N, Demur C, Recher C, Ayel J, Laurent G et al. Tumor necrosis factor-alpha inhibits hTERT gene expression in human myeloid normal and leukemic cells. Blood 2005; 106: 3200–3205; e-pub 14 Jul 2005.

    Article  CAS  Google Scholar 

  9. Freyssinier JM, Lecoq-Lafon C, Amsellem S, Picard F, Ducrocq R, Mayeux P et al. Purification, amplification and characterization of a population of human erythroid progenitors. Br J Haematol 1999; 106: 912–922.

    Article  CAS  Google Scholar 

  10. Janknecht R . On the road to immortality: hTERT upregulation in cancer cells. FEBS Lett 2004; 564: 9–13.

    Article  CAS  Google Scholar 

  11. Chen C, Sytkowski AJ . Erythropoietin activates two distinct signaling pathways required for the initiation and the elongation of c-myc. J Biol Chem 2001; 276: 38518–38526; e-pub 1 Aug 2001.

    Article  CAS  Google Scholar 

  12. Richmond TD, Chohan M, Barber DL . Turning cells red: signal transduction mediated by erythropoietin. Trends Cell Biol 2005; 15: 146–155.

    Article  CAS  Google Scholar 

  13. Zermati Y, Fichelson S, Valensi F, Freyssinier JM, Rouyer-Fessard P, Cramer E et al. Transforming growth factor inhibits erythropoiesis by blocking proliferation and accelerating differentiation of erythroid progenitors. Exp Hematol 2000; 28: 885–894.

    Article  CAS  Google Scholar 

  14. Yang H, Kyo S, Takatura M, Sun L . Autocrine transforming growth factor beta suppresses telomerase activity and transcription of human telomerase reverse transcriptase in human cancer cells. Cell Growth Differ 2001; 12: 119–127.

    CAS  PubMed  Google Scholar 

  15. Lin SY, Elledge SJ . Multiple tumor suppressor pathways negatively regulate telomerase. Cell 2003; 113: 881–889.

    Article  CAS  Google Scholar 

  16. Li H, Xu D, Li J, Berndt MC, Liu JP . Transforming growth factor beta suppresses human telomerase reverse transcriptase (hTERT) by Smad3 interactions with c-Myc and the hTERT gene. J Biol Chem 2006; 281: 25588–25600; e-pub 19 Jun 2006.

    Article  CAS  Google Scholar 

  17. Hu B, Tack DC, Liu T, Wu Z, Ullenbruch MR, Phan SH . Role of Smad3 in the regulation of rat telomerase reverse transcriptase by TGFbeta. Oncogene 2006; 25: 1030–1041.

    Article  CAS  Google Scholar 

  18. Ferraris AM, Mangerini R, Pujic N, Racchi O, Rapezzi D, Gallamini A et al. High telomerase activity in granulocytes from clonal polycythemia vera and essential thrombocythemia. Blood 2005; 105: 2138–2140; e-pub 19 Oct 2004.

    Article  CAS  Google Scholar 

  19. Engelhardt M, Mackenzie K, Drullinsky P, Silver RT, Moore MA . Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture. Cancer Res 2000; 60: 610–617.

    CAS  PubMed  Google Scholar 

  20. Lord JD, McIntosh BC, Greenberg PD, Nelson BH . The IL-2 receptor promotes lymphocyte proliferation and induction of the c-myc, bcl-2, and bcl-x genes through the trans-activation domain of Stat5. J Immunol 2000; 164: 2533–2541.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from the Institut National de la Santé et de la Recherche Médicale, the Association Laurette Fugain, the Association Cent pour Sang La Vie and the Fondation de France. NP-H was supported by a fellowship from the Ligue Nationale contre le Cancer. We are grateful to B Couderc for providing plasmids for retroviral infection. Thanks are due to Monique Laroche and Nicole Lhermie for technical assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to O Beyne-Rauzy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Prade-Houdellier, N., Frébet, E., Demur, C. et al. Human telomerase is regulated by erythropoietin and transforming growth factor-β in human erythroid progenitor cells. Leukemia 21, 2304–2310 (2007). https://doi.org/10.1038/sj.leu.2404874

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404874

Keywords

This article is cited by

Search

Quick links